ResearchIn-Press PreviewHepatology Open Access | 10.1172/jci.insight.181857
1Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America
2Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
3Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, United States of America
4Department of Surgery, University of Michigan, Ann Arbor, United States of America
Find articles by Calder, A. in: JCI | PubMed | Google Scholar
1Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America
2Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
3Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, United States of America
4Department of Surgery, University of Michigan, Ann Arbor, United States of America
Find articles by Peter, M. in: JCI | PubMed | Google Scholar
1Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America
2Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
3Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, United States of America
4Department of Surgery, University of Michigan, Ann Arbor, United States of America
Find articles by Tobias, J. in: JCI | PubMed | Google Scholar |
1Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America
2Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
3Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, United States of America
4Department of Surgery, University of Michigan, Ann Arbor, United States of America
Find articles by Mohamad Zaki, N. in: JCI | PubMed | Google Scholar
1Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America
2Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
3Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, United States of America
4Department of Surgery, University of Michigan, Ann Arbor, United States of America
Find articles by Keeley, T. in: JCI | PubMed | Google Scholar
1Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America
2Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
3Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, United States of America
4Department of Surgery, University of Michigan, Ann Arbor, United States of America
Find articles by Frankel, T. in: JCI | PubMed | Google Scholar |
1Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America
2Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
3Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, United States of America
4Department of Surgery, University of Michigan, Ann Arbor, United States of America
Find articles by Samuelson, L. in: JCI | PubMed | Google Scholar
1Department of Internal Medicine, University of Michigan, Ann Arbor, United States of America
2Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America
3Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, United States of America
4Department of Surgery, University of Michigan, Ann Arbor, United States of America
Find articles by Razumilava, N. in: JCI | PubMed | Google Scholar
Published December 5, 2024 - More info
Biliary obstruction and cholangiocyte hyperproliferation are important features of cholangiopathies affecting the large extrahepatic bile duct (EHBD). The mechanisms underlying obstruction-induced cholangiocyte proliferation in the EHBD remain poorly understood. Developmental pathways, including WNT signaling, are implicated in regulating injury responses in many tissues, including the liver. To investigate the contribution of WNT signaling to obstruction-induced cholangiocyte proliferation in the EHBD, we used complementary in vivo and in vitro models with pharmacologic interventions and transcriptomic analyses. To model obstruction, we used bile duct ligation (BDL) in mice. Human and mouse biliary organoids and mouse biliary explants were used to investigate the effects of WNT activation and inhibition in vitro. We observed an upregulation of WNT ligand expression associated with increased biliary proliferation following obstruction. Cholangiocytes were identified as both WNT ligand-expressing and WNT responsive cells. Inhibition of WNT signaling decreased cholangiocyte proliferation in vivo and in vitro, while activation increased proliferation. WNT effects on cholangiocyte proliferation were β-catenin-dependent, and we showed a direct effect of WNT7B on cholangiocyte growth. Our studies suggested that cholangiocyte-derived WNT ligands can activate WNT signaling to induce proliferation after obstructive injury. These findings implicated the WNT pathway in injury-induced cholangiocyte proliferation within the EHBD.